Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;258(12):2871.
doi: 10.1007/s00417-020-04727-3. Epub 2020 May 8.

Hydroxychloroquine and ritonavir for COVID-19 infection: a possible synergic toxicity for retinal pigmented epithelium

Affiliations

Hydroxychloroquine and ritonavir for COVID-19 infection: a possible synergic toxicity for retinal pigmented epithelium

Mario R Romano et al. Graefes Arch Clin Exp Ophthalmol. 2020 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

    1. Kupferschmidt K, Cohen J (2020) Race to find COVID-19 treatments accelerates. Science 10.1126/science.367.6485.1412 - PubMed
    1. Italian society of infective and tropical disease. (SIMEU) (2020) COVID-19 therapeutic protocol in Lombardia region, Italy. 1–15
    1. Costedoat-Chalumeau N, Dunogué B, Leroux G, et al. A critical review of the effects of hydroxychloroquine and chloroquine on the eye. Clin Rev Allergy Immunol. 2015;49:317–326. doi: 10.1007/s12016-015-8469-8. - DOI - PubMed
    1. Marmor MF, Kellner U, Lai TYY, et al. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision) Ophthalmology. 2016;123:1386–1394. doi: 10.1016/j.ophtha.2016.01.058. - DOI - PubMed
    1. Pasaoglu Isil OFE (2019) Macular toxicity after short-term hydroxychloroquine therapy. Indian J Ophthalmol - PMC - PubMed